Cowley, United Kingdom

Laurent Mounier

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: British Biotech Pharmaceuticals Limited. Active years: 2005-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurent Mounier. Retrieved from https://idiyas.com/inventor/laurent-mounier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2005-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Laurent Mounier

Introduction

Laurent Mounier is a notable inventor based in Cowley, GB. He has made significant contributions to the field of antibacterial agents, holding a total of 2 patents. His work focuses on developing compounds that can effectively combat bacterial infections.

Latest Patents

Mounier's latest patents include innovative antibacterial agents. These compounds are characterized by specific formulas where Q represents a radical of the formula: —N(OH)CH(=O) or —C(=O)NH(OH). The compounds also include various groups such as hydrogen, C-Calkyl, and substituted C-Calkyl, among others. The detailed structure of these compounds highlights their potential effectiveness in treating bacterial infections.

Career Highlights

Laurent Mounier is currently associated with British Biotech Pharmaceuticals Limited. His work at this company emphasizes the importance of research and development in the pharmaceutical industry. Mounier's dedication to innovation has positioned him as a key player in the field of biotechnology.

Collaborations

Some of Mounier's coworkers include Lisa Marie Pratt and Kenneth Noel Keavey. Their collaborative efforts contribute to the advancement of research in antibacterial agents and other pharmaceutical innovations.

Conclusion

Laurent Mounier's contributions to the field of antibacterial agents through his patents and work at British Biotech Pharmaceuticals Limited demonstrate his commitment to innovation in healthcare. His research continues to pave the way for new treatments against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…